March 22, 2024

Abstract 6085: Leveraging targeted epigenetic and genetic detection for cost-effective cancer classification

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract The combinatorial power of genetics and epigenetics is vital to understanding biology in healthy and cancerous states. Utilizing a recent novel approach, we enable the simultaneous identification of modified cytosine and the canonical bases A, C, T Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 6085.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Crawford et al. (Fri,) studied this question.

www.synapsesocial.com/papers/68e72ce8b6db6435876a6f6b — DOI: https://doi.org/10.1158/1538-7445.am2024-6085

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Authors

Robert Crawford

Ben Krajacich

Ermira Lleshi

Journals

Cancer Research

Actions

Institutions

Xenetic Biosciences (United Kingdom)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Abstract 6085: Leveraging targeted epigenetic and genetic detection for cost-effective cancer classification

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion